MEDIUM 6.5

CVE-2026-56402: NanoClaw Privilege Escalation in Approval Handler

NanoClaw versions before 2.1.17 contain a privilege escalation flaw that allows authenticated users to approve or reject sensitive actions—such as package installations—without having the authorization role to do so. An attacker who has legitimate access to the system can exploit a missing validation check in the approval response handler to perform privileged operations they shouldn't be able to execute, potentially installing malicious packages or disrupting system integrity.

Source data · NVD / CISA · public domain

CVSS
3.1 · 6.5 MEDIUM · CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N
Weaknesses (CWE)
CWE-862
Affected products
0 configuration(s)
Published / Modified
2026-06-23 / 2026-06-23

NVD description (verbatim)

NanoClaw before 2.1.17 contains a privilege escalation vulnerability in the handleApprovalsResponse function that fails to verify responder role authorization. Attackers with a valid questionId can approve or reject privileged actions like package installation by submitting approval response payloads without proper role validation.

4 reference(s) · View on NVD →

SEC.co analysis · AI-assisted, reviewed against source

Technical summary

CVE-2026-56402 is a privilege escalation vulnerability in NanoClaw's handleApprovalsResponse function. The flaw stems from insufficient authorization verification when processing approval responses for privileged actions. An attacker with valid network access and valid authentication credentials can craft an approval response payload containing a legitimate questionId without triggering role-based access control checks. This permits unauthorized approval or rejection of protected operations, including package installation, that should be restricted to users with specific approval roles. The vulnerability is network-accessible, requires low attack complexity, and demands only low-level privileges (authenticated user status) to exploit.

Business impact

This vulnerability creates an insider threat risk: authenticated users can escalate their privileges to approve or block critical package installations without proper authorization. In a supply chain or deployment context, a compromised or malicious insider could install backdoored packages, disrupt legitimate deployments, or manipulate system configurations. The impact extends beyond the immediate system to any downstream consumers of deployed packages, making this a potential vector for lateral movement or persistence in multi-system environments.

Affected systems

NanoClaw versions prior to 2.1.17 are affected. Verify your current version and determine whether your environment includes any NanoClaw deployments in approval workflow or package management pipelines. Organizations using NanoClaw for privileged action authorization or continuous deployment are at higher risk.

Exploitability

The attack requires valid authentication credentials and network access to the NanoClaw service. No additional user interaction is needed once the attacker is authenticated. The attack is straightforward: send a specially crafted approval response payload with a known or guessed questionId. The relatively low barrier to exploitation (L in attack complexity, L in privileges required) makes this a practical threat for insider actors or attackers who have compromised legitimate user accounts.

Remediation

Upgrade NanoClaw to version 2.1.17 or later, which implements proper role-based authorization validation in the handleApprovalsResponse function. Organizations unable to patch immediately should implement compensating controls: monitor and audit approval response submissions, restrict network access to the approval endpoint to trusted IP ranges, and enforce multi-factor authentication for accounts with approval privileges. Review logs for suspicious approval activities, especially approvals by users not expected to hold approval roles.

Patch guidance

Obtain and deploy NanoClaw 2.1.17 or a later patched release from the vendor. Verify patch availability in your configured software repository or vendor portal before proceeding. Test the patch in a non-production environment to confirm compatibility with your deployment configuration and any custom integrations. After validation, schedule and execute the upgrade, prioritizing systems that handle critical package deployments or that serve as approval authorities in your workflows.

Detection guidance

Search logs for approval response submissions from user accounts that do not hold documented approval roles. Analyze the handleApprovalsResponse function's audit trail for unusual questionId values or approval patterns inconsistent with normal operations. Monitor for instances where low-privileged users approve high-impact actions like package installations. Network detection should flag repeated approval requests from the same source IP or user within short timeframes. Alert on any approval rejections or approvals that contradict role-based access policy baselines.

Why prioritize this

Although the CVSS score is Medium (6.5), the privilege escalation nature, low barrier to exploitation, and potential for supply chain impact warrant prompt remediation. The vulnerability is not listed on the Known Exploited Vulnerabilities (KEV) catalog at this time, but its practical exploitability makes it a credible near-term risk if an insider is motivated or if a legitimate user account is compromised. Prioritize this update for systems that control package deployment or critical infrastructure provisioning.

Risk score, explained

The CVSS 3.1 base score of 6.5 (MEDIUM) reflects the network-accessible attack vector, low attack complexity, and requirement for low privileges—all factors that increase practical exploitability. However, the scope is unchanged (the vulnerability does not cross trust boundaries) and confidentiality is not impacted; only integrity is at risk. The score appropriately captures a threat that is serious but not catastrophic in isolation. Organizations with high-value package pipelines or sensitive approval workflows should treat this as a higher operational risk and advance its remediation timeline accordingly.

Frequently asked questions

Can an unauthenticated attacker exploit this vulnerability?

No. The vulnerability requires valid authentication credentials and network access to the NanoClaw service. An attacker must first obtain legitimate user credentials or compromise an existing account.

What does 'missing role validation' mean in this context?

The handleApprovalsResponse function accepts an approval payload and processes it without checking whether the user submitting the approval has been granted an approval role. Normally, only users with specific approval roles should be able to approve or reject privileged actions; this check was not performed, allowing any authenticated user to act as an approver.

If I have NanoClaw deployed but not using approval workflows, am I still at risk?

If your NanoClaw instance does not use the approval functionality or privileged action workflows, the practical risk is lower. However, you should still upgrade to 2.1.17 to close the code path and reduce future risks, especially if your deployment model might change.

Are there any workarounds before patching?

Network segmentation and strict access controls to the approval endpoint can reduce risk. Additionally, enforce multi-factor authentication for all NanoClaw users and enable detailed audit logging. These measures do not eliminate the vulnerability but limit exposure while you prepare and test the patch.

This analysis is provided for informational purposes and does not constitute legal or financial advice. Vulnerability details and remediation guidance are based on available source data as of the publication date. Organizations must verify patch availability, compatibility, and applicability to their specific NanoClaw deployments with the vendor. Security decisions should be informed by your risk management framework, asset inventory, and threat landscape. No exploit code or weaponization details are provided. Always test patches in a non-production environment before deploying to critical systems. Source: NVD (public-domain), retrieved 2026-07-29. Analysis generated by SEC.co (claude-haiku-4-5).